← Back to Clinical Trials
Recruiting NCT07420998

NCT07420998 Effect of a Nutritional Product Containing Carob Extract on Carbohydrate Metabolism in Glucose-intolerant Subjects

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07420998
Status Recruiting
Phase
Sponsor Universidad Católica San Antonio de Murcia
Condition Prediabetes
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-01-26
Primary Completion 2026-04

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 65 Years
Study Type INTERVENTIONAL
Interventions
Experimental ProductControl product

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-01-26 with a primary completion date of 2026-04.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Randomized, controlled, double-blind clinical trial with two parallel arms based on the product consumed (experimental product and placebo product) and conducted at a single center, to measure the efficacy of the liquid NUTIFOOD product (nutritional product with carob extract) on carbohydrate metabolism.

Eligibility Criteria

Inclusion Criteria: * Subjects of both sexes aged 18-65 years. * Diagnosis of glucose intolerance according to the American Diabetes Association (at least one of the following criteria): * Impaired fasting glucose (100-125 mg/dl) * Impaired glucose tolerance (oral glucose tolerance test with 2-hour plasma glucose between 140-199 mg/dl) * Glycated hemoglobin between 5.7% and 6.4% * Body mass index between 20-35 kg/m². * Stable dietary habits: no weight gain or loss greater than 5 kg in the last ten weeks. * Volunteers capable of understanding the clinical study and willing to comply with the study procedures and requirements. Exclusion Criteria: * Use of medications that may interfere with glucose metabolism. * Subjects with a history of any type of hepatic or renal disease. * Alcohol consumption greater than 20 g/day. * History of allergic hypersensitivity or poor tolerance to any component of the study products. * Participation in another clinical trial within the three months prior to the study. * Lack of willingness or inability to comply with clinical trial procedures. * Pregnant or breastfeeding women.

Contact & Investigator

Central Contact

Francisco Javier López Román

✉ jlroman@ucam.edu

📞 968278157

Frequently Asked Questions

Who can join the NCT07420998 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Prediabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07420998 currently recruiting?

Yes, NCT07420998 is actively recruiting participants. Contact the research team at jlroman@ucam.edu for enrollment information.

Where is the NCT07420998 trial being conducted?

This trial is being conducted at Murcia, Spain.

Who is sponsoring the NCT07420998 clinical trial?

NCT07420998 is sponsored by Universidad Católica San Antonio de Murcia. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology